#Gennova has developed an mRNA #vaccine for the #OmicronVariant, which will be tested for safety and efficacy for use in humans 💉
Read at https://www.moneycontrol.com/news/india/vaccine-for-omicron-gennova-pharma-makes-indias-1st-strain-specific-covid-vax-govt-to-review-trial-data-7945541.html?utm_source=telegram&utm_medium=social
Read at https://www.moneycontrol.com/news/india/vaccine-for-omicron-gennova-pharma-makes-indias-1st-strain-specific-covid-vax-govt-to-review-trial-data-7945541.html?utm_source=telegram&utm_medium=social
Moneycontrol
Vaccine for Omicron? Gennova Pharma Makes India's 1st Strain-specific Covid Vax, Govt to Review Trial Data
Gennova has developed an mRNA vaccine for the Omicron variant, which will be tested for safety and efficacy for use in humans
The lawsuit by HDT Bio Corp is over an exclusive agreement that gave #Gennova a limited licence to use the US company’s technology to develop and sell a #COVID19 #vaccine in India.
Read more👇
https://www.moneycontrol.com/news/trends/health-trends/indian-maker-of-mrna-vaccine-faces-charges-of-trade-secret-theft-ip-rights-violations-8271561.html?utm_source=telegram&utm_medium=social
Read more👇
https://www.moneycontrol.com/news/trends/health-trends/indian-maker-of-mrna-vaccine-faces-charges-of-trade-secret-theft-ip-rights-violations-8271561.html?utm_source=telegram&utm_medium=social
Moneycontrol
Indian maker of mRNA vaccine faces charges of trade secret theft, IP rights violations
HDT Bio filed a lawsuit in a Seattle court earlier this week, accusing Emcure of misappropriating trade secrets that it had licensed to unit Gennova and seeking $950 million in damages.
#ICYMI: The lawsuit by HDT Bio Corp is over an exclusive agreement that gave #Gennova a limited licence to use the US company’s technology to develop & sell a #COVID19vaccine in India.
Read at 👇
https://moneycontrol.com/news/trends/health-trends/indian-maker-of-mrna-vaccine-faces-charges-of-trade-secret-theft-ip-rights-violations-8271561.html?utm_source=telegram&utm_medium=social
Read at 👇
https://moneycontrol.com/news/trends/health-trends/indian-maker-of-mrna-vaccine-faces-charges-of-trade-secret-theft-ip-rights-violations-8271561.html?utm_source=telegram&utm_medium=social
Moneycontrol
Indian maker of mRNA vaccine faces charges of trade secret theft, IP rights violations
HDT Bio filed a lawsuit in a Seattle court earlier this week, accusing Emcure of misappropriating trade secrets that it had licensed to unit Gennova and seeking $950 million in damages.